Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II trial evaluates pixantrone as part of BSHAP regimen for NHL

Oct. 24, 2003

Rolling NDA submission for clofarabine begins

Oct. 24, 2003

Long-term evaluation of anastrozole and tamoxifen in postmenopausal women with breast cancer

Oct. 24, 2003

Japanese researchers identify c-fos expression modulators for cancer therapy

Oct. 24, 2003

New inhibitors of FAK and other kinases developed at Aventis Pharma

Oct. 24, 2003

TaiGen and TTY Biopharm sign joint development, marketing agreement for DB-67

Oct. 24, 2003

Vion licenses Triapine rights in China, Taiwan, Hong Kong and Macao

Oct. 23, 2003

Novel protein kinase inhibitors identified by Vertex scientists

Oct. 23, 2003

Curacyte claims novel urokinase inhibitors with utility in cancer therapy

Oct. 23, 2003

Roche describes new AKT inhibitors as potential propapoptotic antitumor agents

Oct. 23, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...